コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 benefit rather than sensitivity or positive predictive value.
2 d demonstrated high specificity and positive predictive value.
3 n or if presence of stenosis has independent predictive value.
4 dentified with high specificity and positive-predictive value.
5 had high probability of having high positive predictive value.
6 ysis, sensitivity, specificity, and positive predictive value.
7 ng the Immunoscore, and their prognostic and predictive value.
8 Both exhibit poor positive predictive value.
9 ciated with low specificity and low positive predictive value.
10 atter has been demonstrated to have a higher predictive value.
11 s persistently high sensitivity and negative predictive values.
12 th better sensitivity, and negative/positive predictive values.
13 rve (average precision [AP; average positive predictive value]).
14 1, 0.67), specificity (0.78, 0.88), positive predictive value (0.74, 0.75), and negative predictive v
16 l): 1.573 (0.973-2.541), P = 0.032; positive predictive value = 0.257, negative predictive value = 0.
17 itivity = 0.67, specificity = 0.80, positive predictive value = 0.73 and negative predictive value =
18 ositive predictive value = 0.73 and negative predictive value = 0.74, and disease activity by NAS wit
23 ensitivity 100%, specificity 93.3%, positive predictive value 88.0%), and starting phototherapy after
24 .7%) and had a significantly higher positive predictive value (90.0%, PPV) than QFT (96.5% specificit
26 , 97% [95% CI: 90%, 99%], 68 of 70; negative predictive value, 94% [95% CI: 79%, 98%], 30 of 32).
27 itive predictive value (98.6%), and negative predictive value (95.6%) as compared with >=20 and >=60
28 , 94% [95% CI: 79%, 99%], 30 of 32; positive predictive value, 97% [95% CI: 90%, 99%], 68 of 70; nega
30 ivity (99.3%), specificity (91.0%), positive predictive value (98.6%), and negative predictive value
31 cute on chronic" renal dysfunction (negative predictive value, 98.0%; sensitivity, 92.9%; specificity
32 patients with acute kidney injury (negative predictive value, 98.8%; sensitivity, 95.8%; specificity
33 ce interval [CI]: 81.5%, 93.6%) and negative predictive value (99.1% [1528 of 1542]; 95% CI: 98.5%, 9
34 Tumour mutational burden might have some predictive value, although blood-based measures of tumou
35 ECG, CineECG at baseline had a 100% positive predictive value and 81% negative predictive value in pr
36 31/200) and 96.6% (170/176), with a positive predictive value and negative predictive value of 83.8%
38 icted more lymph nodes and improved positive predictive value and specificity when added to multipara
39 to detect cell-type markers, impacting their predictive value and suitability for integration into re
40 sitivity, specificity, positive and negative predictive values and accuracy and discriminant property
41 nd 0.37 and 0.94, respectively, and positive predictive values and negative predictive values ranged
43 ody tests (quality, accuracy level, positive predictive value) and what those tests might indicate im
44 e in patients with a sensitivity, a negative predictive value, and a specificity of 71.4%, 87.5%, and
45 ificity, positive predictive value, negative predictive value, and accuracy and to evaluate the estim
46 ificity, positive predictive value, negative predictive value, and accuracy for diagnosis of COVID-19
47 sitivity, specificity, positive and negative predictive value, and accuracy for LNM detection on (68)
48 ificity, positive predictive value, negative predictive value, and accuracy were calculated based on
49 itivity, positive predictive value, negative predictive value, and accuracy were determined for all m
50 ificity, positive predictive value, negative predictive value, and accuracy) were calculated based on
51 itivity, positive predictive value, negative predictive value, and accuracy, were higher in off MAR c
53 tudy were sensitivity, specificity, positive predictive value, and negative predictive value based on
54 lated the sensitivity, specificity, positive predictive value, and negative predictive value for the
55 ssess its sensitivity, specificity, positive predictive value, and negative predictive value in ident
57 a, showed sensitivity, specificity, positive predictive value, and negative predictive value of 86% (
60 sitivity, specificity, negative and positive predictive values, and negative and positive likelihood
61 rtex multimodal classifier had a significant predictive value (area under the curve, 0.96; 95% CI, 0.
62 dinal changes of retinal thickness and their predictive value as biomarkers of disease progression in
63 ity, positive predictive value, and negative predictive value based on infants testing positive in bo
64 Quantitative CT measures added incremental predictive value beyond a model with only clinical param
65 was to evaluate if obstructive CAD provides predictive value beyond its association with total calci
66 FDG PET/CT had good specificity and positive predictive value but low to moderate sensitivity and neg
67 o show that immune profiling has substantial predictive value, but few studies focus on childhood tum
68 for associations between microbes had higher predictive value compared to models including moose sex,
69 igands with 1.5-fold improvement in positive predictive value compared with existing tools and correc
70 long corresponding percentiles, the positive predictive value curves for qPET and DeltaSUV(max) were
72 y are limited to few parameters with minimal predictive value, despite some contributions to disease
74 range, 25-94 years), resulting in a positive predictive value for biopsy of 43% (181 true-positive fi
75 the first months post-onset, with a positive predictive value for clinically relapsing disease of onl
77 are CysC-eGFR and sCr-eGFR, (2) assess their predictive value for early postoperative outcomes, and (
78 eristic curve 0.83 [0.73-0.93]) had the best predictive value for ICU mortality with cutoff values le
79 SPOT.TB, and TST modestly increases positive predictive value for incident TB, but markedly reduces s
80 ce per se, being heritable and having unique predictive value for long-term memory function, hippocam
82 01), resulting in a decrease in the positive predictive value for recall for suspicious microcalcific
85 rtheless, CT alone may have limited negative predictive value for ruling out SARS-CoV-2 infection, as
87 ed a unique low-dose BPA-gene signature with predictive value for survival outcomes in patients with
88 but low to moderate sensitivity and negative predictive value for the detection of PTLD in a 28-pedia
91 evelopment of diagnostic tools with improved predictive value for tuberculosis (TB) is a global resea
93 with 100% negative (NPV) and positive (PPV) predictive values for a positive gold standard functiona
94 ) assays have been recently shown to provide predictive values for both cardiac and peripheral microa
95 n EPIONCHO-IBM but not ONCHOSIM) on positive predictive values for different serological thresholds.
98 .92, specificity from 0.83 to 0.97, positive predictive value from 0.70 to 0.93, and negative predict
100 st characteristics remained stable: negative predictive value (> 99%), sensitivity (91.2% vs 93.4%),
101 However, low sensitivity and low positive predictive value have led critics to argue that these to
108 res of tumour mutational burden did not have predictive value in patients receiving atezolizumab plus
109 % positive predictive value and 81% negative predictive value in predicting ajmaline test results.
110 he harmonic mean of sensitivity and positive predictive value) in the training set was applied to the
113 tool; however, the sensitivity and positive predictive value may be lower than previously reported w
114 excellent sensitivity, specificity, positive predictive value, negative predictive value, and accurac
115 z value), specificity, sensitivity, positive predictive value, negative predictive value, and accurac
116 metrics (sensitivity, specificity, positive predictive value, negative predictive value, and accurac
118 ifier for sensitivity, specificity, positive predictive value, negative predictive value, and accurac
120 ures were sensitivity, specificity, positive predictive value, negative predictive value, positive an
121 92.2% to 97.9%), respectively, with negative predictive value (NPV) (100%), positive predictive value
122 formance criteria were at least 90% negative predictive value (NPV) and at least 90% sensitivity for
123 rimary endpoint was to estimate the negative predictive value (NPV) and positive predictive value (PP
125 109/L at presentation, which had a negative predictive value (NPV) for likely bacterial pneumonia of
128 e predictive value (PPV) of 86% and negative predictive value (NPV) of 99% was achieved for the diagn
130 ositive predictive value (PPV), and negative predictive value (NPV) of CryptoPS were assessed against
131 ositive predictive value (PPV), and negative predictive value (NPV) of STs for metronidazole/ornidazo
132 ositive predictive value (PPV), and negative predictive value (NPV) were calculated for each examiner
133 ositive predictive value (PPV), and negative predictive value (NPV) were calculated for MRI using CT
135 y, positive predictive value (PPV), negative predictive value (NPV), and positive and negative likeli
136 Positive predictive value (PPV), negative predictive value (NPV), sensitivity, specificity, and ka
137 entire population, expressed as the negative predictive value (NPV), using ICA as the reference stand
141 pecificity of 93%, and negative and positive predictive values (NPV and PPV) of 82% and 93%, respecti
143 ity, positive predictive value, and negative predictive value of (18)F-FDG PET/CT for the detection o
144 ysis with log-rank was used to determine the predictive value of (64)Cu-DOTATATE SUV(max) for OS and
146 ity of 100% (95% CI 72%-100%) and a negative predictive value of 100%, as compared to a sensitivity o
149 of 5.9% (95% CI, 2.6%-12.2%), and a negative predictive value of 100.0% (95% CI, 100.0%-100.0%).
150 tivity of 24% (95% CI 8%-50%) and a negative predictive value of 19% (95% CI 5%-46%) for the index te
151 ity of 90%, a specificity of 71%, a positive predictive value of 32%, and a negative predictive value
152 e machine learning model has a mean positive predictive value of 34.6% [SD: 0.15] for flagging the to
153 y of 99.9% (95% CI, 99.9%-99.9%), a positive predictive value of 5.9% (95% CI, 2.6%-12.2%), and a neg
155 of 93.3%, a specificity of 76.5%, a positive predictive value of 77.8%, and a negative predictive val
158 ith a positive predictive value and negative predictive value of 83.8% (31/37) and 50.1% (170/339), r
159 ity, positive predictive value, and negative predictive value of 86% (119 of 139), 96% (55 of 57), 98
160 itivity of 82%, specificity of 93%, positive predictive value of 86%, and negative predictive value o
161 ity of 100%, specificity of 92.31%, positive predictive value of 87.5%, and negative predictive value
162 of 94.5%, a specificity of 94.4%, a positive predictive value of 88.0%, and a negative predictive val
163 nsity thresholds, a specificity and negative predictive value of 89% and 95% were achieved, respectiv
165 e" (n = 123) pattern demonstrated a positive predictive value of 89.6% and 86.2% for non-COVID-19, re
168 allowing to predict treatment outcome with a predictive value of 93.8% when combined with clinical fe
172 h a secondary finding and the lower positive predictive value of a screening result compared to an in
173 eport the patient-level CDR and the positive predictive value of AB-MR examinations after negative/be
174 olling for age and biomarker elevations; the predictive value of adverse RV remodeling was similar ir
176 than TST (54.2%) and TSPOT (51.9%); negative predictive value of all tests was high (TST 97.7%, QFT 9
178 g complete PVD was 53%, whereas the negative predictive value of an OCT scan showing attached vitreou
181 genetic information added little to the high predictive value of baseline severity of AMD for disease
183 value of recall (PPV1) percentage, positive predictive value of biopsies performed percentage, sensi
184 lue of an abnormal examination, and positive predictive value of biopsy were 114 of 114 (100%; 95% CI
187 istic regression was performed to assess the predictive value of clinical and CT parameters for the p
188 increased to 97.4% in 2015, and the positive predictive value of CT and combined CT and ultrasonograp
191 In the same cohort, sensitivity and negative predictive value of depth of invasion, currently the bes
192 The negative predictive value and positive predictive value of DUS were 92% (95% CI, 90-95) and 39%
193 dge Base (LTKB) have been used to derive the predictive value of each end point, along with combinati
194 erventions on cancer outcomes as well as the predictive value of geriatric assessment in the context
195 his study was to evaluate the prognostic and predictive value of HLA-G and HLA-F protein isoform expr
196 re are subtle sex-related differences in the predictive value of individual biomarkers, but the overa
197 ncident cancer cases), we quantify the added predictive value of integrating cancer-specific PRS with
198 s, response to subsequent therapies, and the predictive value of molecular and genetic characteristic
199 etrospectively addressed the question of the predictive value of molecular events on the benefit of t
202 the ME panel test utilization rate, negative predictive value of nonpleocytic CSF samples, test yield
205 -based testing as the standard, the negative predictive value of PCR was found to be 100%, while the
206 otype of FGR in women with AMSB and test the predictive value of placental sonographic screening to p
207 limiting membrane at 3 months is a positive predictive value of postoperative BCVA 6 months after in
209 The aim of this study was to evaluate the predictive value of PSMA PET for a 3-y freedom from prog
210 ative rate per 1000 women screened, positive predictive value of recall (PPV1) percentage, positive p
211 ngs, biopsy, cancer detection rate, positive predictive value of recalls and biopsies, and histopatho
213 incidence, and treatments, plus the positive predictive value of screening mammography by age group.
214 origin of the aneuploidy and the diagnostic predictive value of segmental aneuploidy detection in TE
216 y of MPS cellular phenotypes and the limited predictive value of surface markers to define lineages,
218 ps when receiving standard chemotherapy, the predictive value of the genetic background and co-occurr
223 and demonstrate the scientific validity and predictive value of this approach using an assortment of
225 ed probability of hearing loss, the positive predictive value of this model was 83% and negative pred
226 We explored the clinical significance and predictive value of trans-ethnic variants in multiple po
229 vity, specificity, and positive and negative predictive values of 18F-FDG-PET/CT focal uptake were 93
232 is low, a large gap exists between positive predictive values of chest CT versus those of reverse tr
233 ther epilepsy centers was used to assess the predictive values of each model and regional anatomical
234 how activating ESR1 mutations may alter the predictive values of molecular imaging agents for endocr
235 vity, specificity, and positive and negative predictive values of the panel compared to myco/f lytic
236 cond ECG yielded a sensitivity (and negative predictive value) of 1.5% (66%) for AF detection, increa
237 ), 93% specificity (132 of 142), 9% positive predictive value (one of 11), and 97% negative predictiv
238 relative performance (sensitivity, positive predictive value or PPV, and computational efficiency) o
239 P = .52 and P = .98, respectively), positive predictive value (P = .78), or sensitivity (P = .33) for
240 ificity, positive predictive value, negative predictive value, positive and negative likelihood ratio
242 included sensitivity, specificity, negative predictive value, positive predictive value, and accurac
243 tive predictive value (NPV) (100%), positive predictive value (PPV) (63.5%), and area under the curve
244 sis-based detection sensitivity and positive predictive value (PPV) at a 50% confidence threshold.
245 ith the individual assays), and the positive predictive value (PPV) improved substantially, with a mi
246 negative predictive value (NPV) and positive predictive value (PPV) occurred when iPET was defined as
247 e the sensitivity, specificity, and positive predictive value (PPV) of (18)F-DCFPyL PET/CT based on h
248 BATF2, GBP5, and SCARF1 achieved a positive predictive value (PPV) of 23% for progression to active
249 itivity of 86%, specificity of 58%, positive predictive value (PPV) of 57% and negative predictive va
250 tified patients at high risk with a positive predictive value (PPV) of 76.8% (95% CI: 68.9% to 83.6%)
252 al imaging recommendation rate, and positive predictive value (PPV) of biopsy, using invasive cancer
254 predictor led to an increase in the positive predictive value (PPV) of the peptides correctly predict
257 ection rate (CDR), recall rate, and positive predictive value (PPV) were calculated for each reader,
258 y (95% CI, 82%-100%) and up to 100% positive predictive value (PPV) with estimated negative predictiv
259 to assess the detection rate (DR), positive predictive value (PPV), and correct detection rate (CDR)
262 imated as sensitivity, specificity, positive predictive value (PPV), and negative predictive value (N
265 lated the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV),
266 metrics (sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV),
268 itivity: 88.9%; specificity: 72.4%; Positive predictive value (PPV): 50%; Negative predictive value (
270 and positive predictive values and negative predictive values ranged between 0.59 and 0.92 and 0.57
272 erval [CI]: 86.8% to 94.1%) and the positive predictive value, sensitivity, and specificity were 87.9
273 gative rate, cancer detection rate, positive predictive value, sensitivity, and specificity were calc
275 likelihood ratios, and positive and negative predictive values to determine the diagnostic performanc
277 cancer detection and recall rates, positive predictive values, tumor size, histologic features, and
282 ty was 100%, specificity was 51.1%, positive predictive value was 21.8%, and negative predictive valu
288 e was 86.3% (95% CI, 80.4 to 90.6), negative predictive value was 99.3% (95% CI, 98.0 to 99.8) with a
289 sensitivity was high (67%), but the positive predictive value was low, as only 8% of TWAS association
290 ity, positive predictive value, and negative predictive value were reported for each radiotracer.
293 ity, positive predictive value, and negative predictive values were 73.9%, 78.4%, 68.0%, and 82.9%, r
294 ecificity, positive predictive, and negative predictive values were 76.5%, 77.3%, 72.2%, and 81.0% wi
295 14.8% and 26.2%, respectively, and negative predictive values were 91.6% and 86.4%, respectively.
297 SN), specificity (SP), positive and negative predictive values were performed for all questions alone
299 53 serious adverse events with high positive predictive values where well-characterized target-event
300 -up, there was a modest increase in positive predictive value with the higher thresholds (3.0% for QF